Sean Jiang, the CEO of Yafo Capital, participated 19th Annual Biotech in Europe Forum from 25th - 26th September 2019 at the Congress Center Basel, Switzerland. The forum provides access to an exciting cross-section of venture-funded and small-cap companies with leading investors and pharmas. Over 700 delegates and over 100 presenting companies, and 30+ pitches by seed companies have been involved.
Yafo capital received the “2019 Best Pharma BD Innovation Award” at the 14th China Pharmaceutical and Medtech Business Development Forum, hosted by Luye Pharmaceutical and Weijian Pharmaceutical. The Forum is organized by China Healthcare Business Development (CHBD) and Yafo Capital acts as the Forum’s designated transaction partner. Yafo Capital presented 4 overseas pharma transaction opportunities at the conference.
YAFO Capital office welcomed more than 20 pharmaceutical leaders to join the salon, including executives and BD Directors from Ferring Pharmaceuticals, Sinopharma, Tasly Group, CR Pharmaceutical, Wuxi Apptec, Tenry Pharmaceutical, etc.
IRVINE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced it has signed an exclusive sales and distribution agreement with MaxHealth for the sale of its EZ Detect product in China. The agreement requires MaxHealth to meet annual minimum purchase requirements, which in aggregate, equal $17 million. As previously announced, the CFDA has already cleared Biomerica’s EZ Detect™ colorectal screening test for distribution in China.
On June 3rd, 2019, Mr. Cai Wei, the head of R&D Center of Yangtze River Pharmaceutical Group(YRPG), visited YAFO Capital Shanghai office with its team. YRPG has ranked No. 1 for many years among all Chinese pharmaceutical companies (Data reported by China Ministry of Industry and Information Technology).
Comparing to the US and China, number of successful start-ups and bioventures in the healthcare sector are fewer in Japan nevertheless there are many cutting edge disruptive science from Japanese academia. What are the reasons behind?
August 8, 2018 - Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) announced yesterday that the company had entered into a license agreement with Luoxin Pharmaceutical Group Co., Ltd., Shandong (Luoxin). Yafo Capital acted as the exclusive financial advisor on this transaction.
In Feb. 2018, Yafo Capital announced a joint venture with the Nutrition & Health Research Institute (NHRI) of COFCO (China National Cereals, Oils and Foodstuffs Corporation), the world’s third largest agriculture company, to expand into nutrition and health market and agro sector. The JV will be the first IP/tech-transfer company under Central State-Owned Enterprises (CSOEs).
On November 30, 2017，Yafo Capital reached a strategic partnership with Xixian Financial Holdings, a wholly owned subsidiary of Xixian New Area, China's seventh State-level development district , to invest and bring global technologies to China. Yafo Capital and Xixian Capital agreed to set up an investment fund of 5 billion RMB, with a first phase of 1 billion RMB, that will focus on healthcare, green-tech, food and agro tech, TMT, advanced manufacturing and other sectors. The fund will invest in foreign enterprises in the above sectors, aiming to bring global products and/or technologies to China in order to penetrate the Chinese market.
Benjamin Peng, from Yafo Capital, shared his insights about China-Israel investment and business opportunities at the The 5th One Belt, One Road Initiative conference panel discussion on September 26th, 2017.
It is an NGO represented at the United Nations Organization, the European Council, UNESCO and the MERCOSUR. The numerous lodges of the B’nai B’rith (Sons of the Brith) have been created by some Free Masons. They have all over the USA, South America, Europe, Australia and Israel- wherever Jewish communities exist.
In 2016, the Hillel of Silicon Valley honored Yafo’s own Qi Li for her Israel advocacy work in both the US and China. She is the first Chinese and alumni student to be honored by the L’Dor V’Dor (“From Generation to Generation”) program in Hillel of Silicon Valley.
A Yafo Capital sponsored art exhibition called “Love without Boundaries – Jewish Refugees in Shanghai” opened at the International Convention Center in Jerusalem on May 10th. The exhibition enshrined the history of Jews seeking shelter in Shanghai during WWII.
Following the YAFO JPM Mixing Dinner 2019, YAFO Capital together with Renexes and CHBD will provide an exciting Pre-JPM networking event that combining ski and fireside chat this year. The Mixing Dinner in San Francisco will include 50 to 100 people this year from China, Japan and US. The Pre-JPM Ski Tahoe and the Bio Fireside Chat event will be held at a ski resort in Lake Tahoe.
In 2010, recognizing that the healthcare reform and industry growth was spurring a new wave of emerging Chinese healthcare companies, a group of investors led the efforts to organize China Healthcare Investment Conference (CHIC). This prestigious event has since grown into the most powerful platform to promote and nurture the Chinese healthcare investment ecosystem and further develop the industry.